TIRELLI, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 769
EU - Europa 201
AS - Asia 152
OC - Oceania 1
Totale 1.123
Nazione #
US - Stati Uniti d'America 763
CN - Cina 109
UA - Ucraina 81
DE - Germania 46
FI - Finlandia 34
HK - Hong Kong 22
IE - Irlanda 14
IN - India 13
GB - Regno Unito 9
FR - Francia 7
IT - Italia 6
CA - Canada 5
IR - Iran 4
SE - Svezia 2
AU - Australia 1
BD - Bangladesh 1
HU - Ungheria 1
JP - Giappone 1
LU - Lussemburgo 1
MS - Montserrat 1
SG - Singapore 1
TR - Turchia 1
Totale 1.123
Città #
Woodbridge 125
Fairfield 91
Houston 69
Jacksonville 65
Ashburn 63
Ann Arbor 52
Chandler 49
Seattle 46
Cambridge 42
Wilmington 39
Nanjing 33
Princeton 27
Beijing 22
Hong Kong 22
Helsinki 21
Dublin 14
New York 12
Nanchang 10
San Diego 9
Tianjin 7
Des Moines 6
Shenyang 6
Jinan 5
Toronto 5
Ardabil 4
Kunming 4
Shanghai 4
Changsha 3
Hebei 3
Lancaster 3
Milan 3
Guangzhou 2
Jiaxing 2
Los Angeles 2
Norwalk 2
Brescia 1
Changchun 1
Dhaka 1
Haikou 1
Hangzhou 1
Lanzhou 1
Leawood 1
Luxembourg 1
Melbourne 1
Monza 1
Ningbo 1
Pune 1
San Francisco 1
Taizhou 1
Verona 1
Zhengzhou 1
Totale 888
Nome #
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 117
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 106
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 101
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 98
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 97
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 97
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 94
Observational Study on HIV-Infected Subjects Failing HAART Receiving Tenofovir Plus Didanosine as NRTI Backbone. 88
Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection. 85
Lopinavir plasma levels in salvage regimens by a population of highly active antiretroviral therapy-treated HIV-1-positive patients. 60
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case 50
Current concerns in HIV antiretroviral therapy 49
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 49
Infezione da HIV. Terapia 37
Totale 1.128
Categoria #
all - tutte 3.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201983 0 0 0 0 0 0 0 0 0 0 43 40
2019/2020320 50 10 9 46 18 32 30 32 27 40 9 17
2020/2021170 3 16 4 23 5 29 5 21 27 13 17 7
2021/202299 7 9 0 4 0 9 4 4 6 15 9 32
2022/2023125 15 4 0 4 12 43 0 11 21 0 5 10
2023/202481 6 1 7 20 1 17 1 4 22 2 0 0
Totale 1.128